Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.97% | 136.25 | 0.0% | $893.93m | |
| AMGN | Amgen, Inc. | 1.12% | 247.50 | 1.5% | $828.95m | |
| GILD | Gilead Sciences, Inc. | 0.90% | 63.84 | 1.0% | $542.01m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.23% | 258.59 | 1.9% | $461.95m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.61% | 661.14 | 2.6% | $422.10m | |
| ILMN | Illumina, Inc. | 1.14% | 243.49 | 3.3% | $313.80m | |
| NVAX | Novavax, Inc. | -8.57% | 53.42 | 75.7% | $307.51m | |
| BIIB | Biogen, Inc. | 3.40% | 199.65 | 1.8% | $240.05m | |
| BNTX | BioNTech SE | -2.90% | 163.00 | 0.0% | $226.41m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 1.93% | 2.11 | 0.7% | $147.50m | |
| EXAS | EXACT Sciences Corp. | -1.54% | 53.17 | 17.7% | $147.09m | |
| TXG | 10X Genomics, Inc. | 0.58% | 50.16 | 0.0% | $101.29m | |
| TECH | Bio-Techne Corp. | -0.03% | 366.35 | 4.5% | $100.80m | |
| NKTX | Nkarta, Inc. | -1.78% | 12.67 | 0.0% | $99.26m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.56% | 79.72 | 4.2% | $98.40m |
Company Profile
Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.